Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).
Apply
Mosunetuzumab & Polatuzumab
CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step